Persistent microbial material contributes to Alzheimer disease and is targetable by vaccination
Marcet, E. C.; Vinacur, M.; Zaidi, T.; Nguyen, N.; Augart-Welwood, A.; Su, G.; Landau, D.; LaVancher, E.; Arkhangelskiy, A.; Power, L. H.; Kelly, M. E.; Stein, C. R.; Carolan, E.; Caldarone, B.; Lemere, C. A.; Wasen, C.; Cox, L. M.; Cairns, D. M.; Kaplan, D.; Pier, G. B.; Cywes-Bentley, C.
Show abstract
Chronic neuroinflammation is increasingly recognized as a contributor to Alzheimer disease, yet the upstream stimuli that sustain it remain poorly defined. We investigated whether persistent microbial material contributes to Alzheimer disease using the conserved microbial polysaccharide poly-N-acetylglucosamine (PNAG). PNAG-containing microbial material colocalized with amyloid plaques in human Alzheimer disease brain tissue. In fully human neuronal and three-dimensional brain models, purified PNAG and PNAG-containing microbial vesicles activated Toll-like receptor 2-dependent inflammasome signaling and promoted amyloid-{beta} and phosphorylated tau accumulation. Vaccination targeting PNAG improved cognition, reduced glial activation and amyloid pathology, remodeled amyloid processing, and preserved gut microbial community structure in APP/PS1 mice. These findings identify persistent microbial material as an upstream contributor to Alzheimer disease-associated neuroinflammation and a potential therapeutic target.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina 95%
- Novel brain-penetrant inhibitor of G9a methylase blocks Alzheimer’s disease proteopathology for precision medication 94%
- Aβ42 oligomers trigger synaptic loss through CAMKK2-AMPK-dependent effectors coordinating mitochondrial fission and mitophagy 94%
Similar papers in this journal
Similar papers in this journal
- ACSS2 upregulation enhances neuronal resilience to aging and tau-associated neurodegeneration 96%
- PTP1B inhibition promotes microglial phagocytosis in Alzheimer's disease models by enhancing SYK signaling 94%
- Amyloid Beta Glycation Induces Neuronal Mitochondrial Dysfunction and Alzheimers Pathogenesis via VDAC1-Dependent mtDNA Efflux 94%
Similar papers in this journal
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 95%
- DAP12 deficiency alters microglia-oligodendrocyte communication and enhances resilience against tau toxicity 95%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 94%
Similar papers in this journal
- Glucose hypometabolism and hyperphosphorylated Tau synergistically drive neuronal necroptosis 94%
- Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model 94%
- The Alzheimers Disease Risk Genes MS4A4A And MS4A6A Cooperate to Negatively Regulate Trem2 and Microglia states 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.